XBiotech Inc

XBIT

Company Profile

  • Business description

    XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

  • Contact

    5217 Winnebago Lane
    AustinTX78744
    USA

    T: +1 512 386-2900

    E: [email protected]

    http://www.xbiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    92

Stocks News & Analysis

stocks

Investors overly negative on undervalued ASX share

Road to profitability is in sight as management continues to take the right steps.
stocks

Reporting season preview: February 2025

As of Wednesday, 24 companies under coverage have reported; you’ll find our analysis throughout this issue.
stocks

Signs of a turnaround for undervalued ASX share

Market likes the payoff from early efforts at reining in costs.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,811.9013.20-0.15%
CAC 408,184.415.870.07%
DAX 4022,705.62192.200.85%
Dow JONES (US)44,546.08165.35-0.37%
FTSE 1008,752.6120.150.23%
HKSE22,616.234.10-0.02%
NASDAQ20,026.7781.130.41%
Nikkei 22539,174.2524.820.06%
NZX 50 Index13,068.9379.750.61%
S&P 5006,114.630.44-0.01%
S&P/ASX 2008,537.1018.70-0.22%
SSE Composite Index3,355.839.110.27%

Market Movers